What is HC Wainwright’s Estimate for Quantum-Si Q2 Earnings?

Quantum-Si incorporated (NASDAQ:QSI) – HC Wainwright reduced their Q2 2025 earnings per share (EPS) estimates for Quantum-Si in a note issued to investors on Thursday, November 21st. HC Wainwright analyst S. Ramakanth now expects that the company will post earnings of ($0.19) per share for the quarter, down from their prior forecast of ($0.17). HC Wainwright has a “Buy” rating and a $5.50 price objective on the stock. The consensus estimate for Quantum-Si’s current full-year earnings is ($0.65) per share. HC Wainwright also issued estimates for Quantum-Si’s Q3 2025 earnings at ($0.19) EPS, Q4 2025 earnings at ($0.19) EPS, FY2025 earnings at ($0.75) EPS, FY2026 earnings at ($0.69) EPS and FY2027 earnings at ($0.51) EPS.

Separately, Canaccord Genuity Group cut their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating on the stock in a research note on Wednesday, November 13th.

Quantum-Si Trading Up 33.9 %

QSI stock opened at $1.62 on Monday. The business’s fifty day moving average price is $0.87 and its 200 day moving average price is $1.08. Quantum-Si has a 12-month low of $0.61 and a 12-month high of $2.43. The company has a market capitalization of $231.20 million, a PE ratio of -2.53 and a beta of 2.89.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio purchased a new position in Quantum-Si in the first quarter worth approximately $27,000. XTX Topco Ltd purchased a new stake in shares of Quantum-Si during the 2nd quarter worth $25,000. Virtu Financial LLC purchased a new stake in shares of Quantum-Si during the 1st quarter worth $98,000. Price T Rowe Associates Inc. MD grew its stake in shares of Quantum-Si by 11.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock worth $118,000 after purchasing an additional 5,945 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in Quantum-Si in the third quarter valued at $53,000. 39.90% of the stock is currently owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.